Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile

The elevated expression of histone deacetylases (HDACs) in various tumor types renders their inhibition an attractive strategy for epigenetic therapeutics. One key issue in the development of improved HDAC inhibitors (HDACis) is the selectivity for single HDAC isoforms over unspecific pan inhibition...

Full description

Saved in:
Bibliographic Details
Published inChemical science (Cambridge) Vol. 12; no. 35; pp. 11873 - 11881
Main Authors Selg, Christoph, Schöler, Andrea, Schliehe-Diecks, Julian, Hanl, Maria, Sinatra, Laura, Borkhardt, Arndt, Sárosi, Menyhárt B, Bhatia, Sanil, Hey-Hawkins, Evamarie, Hansen, Finn K
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 15.09.2021
The Royal Society of Chemistry
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The elevated expression of histone deacetylases (HDACs) in various tumor types renders their inhibition an attractive strategy for epigenetic therapeutics. One key issue in the development of improved HDAC inhibitors (HDACis) is the selectivity for single HDAC isoforms over unspecific pan inhibition to minimize off-target toxicity. Utilizing the carborane moiety as a fine-tuning pharmacophore, we herein present a robust solid phase synthetic approach towards tailor-made HDACis meeting both ends of the selectivity spectrum, namely pan inhibition and highly selective HDAC6 inhibition. This work describes a versatile solid phase synthesis of carborane-capped histone deacetylase inhibitors with a tunable selectivity profile and synergistic anticancer activity with bortezomib.
Bibliography:10.1039/d1sc02268g
Electronic supplementary information (ESI) available. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-6520
2041-6539
DOI:10.1039/d1sc02268g